Moonlake Immunotherapeutics
(MLTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MLTX | AZN | AMGN | GILD | BMY |
| Company | Moonlake Immunotherapeutics | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 15.50 | 191.80 | 380.70 | 151.85 | 61.37 |
| High | 15.87 | 192.76 | 384.62 | 153.00 | 61.63 |
| Low | 15.23 | 188.34 | 372.34 | 150.18 | 60.53 |
| Latest | 15.58 | 188.77 | 374.62 | 150.77 | 60.67 |
| Change | +0.07 | -4.26 | -9.70 | -1.73 | -1.32 |
| % Change | +0.45% | -2.21% | -2.52% | -1.13% | -2.13% |
| Volume | 364,884 | 1,721,716 | 1,209,499 | 3,661,614 | 6,139,518 |
| 20-Day Average Volume | 1,630,580 | 4,765,504 | 3,038,105 | 7,994,424 | 13,293,884 |
| Previous Close | 15.51 | 193.03 | 384.32 | 152.50 | 61.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 16.13 | 187.11 | 345.40 | 135.98 | 56.24 |
| 20-Day Raw Stochastic | 28.18% | 68.91% | 80.96% | 92.03% | 84.19% |
| 20-Day Relative Strength | 51.69 | 53.95 | 64.41 | 73.06 | 67.97 |
| Weighted Alpha | +61.96 | +32.91 | +35.51 | +53.31 | +24.26 |
| Today's Opinion | 40% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 96% Buy | 40% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.63% since 02/02/26 | +0.33% since 02/02/26 | +8.12% since 02/02/26 | +5.30% since 02/02/26 | +8.62% since 02/02/26 |
| Low | 14.47 on 02/04/26 | 183.63 on 02/03/26 | 338.59 on 02/03/26 | 142.03 on 02/03/26 | 55.49 on 02/03/26 |
| High | 16.16 on 02/03/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 1-Month | |||||
| %Chg | -15.14% since 01/09/26 | -0.14% since 01/09/26 | +14.28% since 01/09/26 | +24.24% since 01/09/26 | +8.67% since 01/09/26 |
| Low | 14.47 on 02/04/26 | 178.08 on 01/21/26 | 319.79 on 01/13/26 | 119.63 on 01/12/26 | 53.54 on 01/21/26 |
| High | 18.80 on 01/12/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 3-Month | |||||
| %Chg | +47.60% since 11/07/25 | +11.75% since 11/07/25 | +16.39% since 11/07/25 | +26.61% since 11/07/25 | +30.02% since 11/07/25 |
| Low | 10.52 on 11/10/25 | 171.69 on 11/10/25 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 45.26 on 11/20/25 |
| High | 18.80 on 01/12/26 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| 6-Month | |||||
| %Chg | -70.06% since 08/08/25 | +28.50% since 08/08/25 | +29.30% since 08/08/25 | +26.00% since 08/08/25 | +32.11% since 08/08/25 |
| Low | 5.95 on 09/29/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 42.52 on 10/29/25 |
| High | 62.75 on 09/26/25 | 193.97 on 02/06/26 | 385.12 on 02/06/26 | 153.13 on 02/06/26 | 62.05 on 02/06/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 996,223 | 299,371,776 | 206,949,024 | 189,203,696 | 126,196,336 |
| Shares Outstanding, K | 64,231 | 1,550,908 | 538,481 | 1,240,680 | 2,035,753 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 48,300,000,000 |
| Annual Net Income | -118,940,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -8,948,000,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 12,222,000,000 |
| Last Quarter Net Income | -69,730,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 2,201,000,000 |
| 60-Month Beta | 1.21 | 0.34 | 0.46 | 0.36 | 0.29 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.10 on 11/05/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 1.26 on 02/05/26 |
| Latest Earnings Date | 02/25/26 | 02/10/26 | 05/07/26 | 02/10/26 | 04/23/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | 0.630 on 01/02/26 |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | 01/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.48 | 16.83 | 18.24 | 9.68 |